[Cardiac rehabilitation in patients with myocardial infarction: a 10-year follow-up study]

José M Maroto Montero1, Rosario Artigao Ramírez, María D Morales Durán

  • 1Unidad de Rehabilitación Cardíaca, Instituto de Cardiología, Hospital Ramón y Cajal, Madrid, Spain. jmmmcp@yahoo.es

Insights

Cardiac rehabilitation programs significantly improve long-term survival in patients after acute myocardial infarction. This structured intervention reduces mortality and morbidity, enhancing recovery and patient outcomes.

Area of Science:

  • Cardiology
  • Public Health
  • Preventive Medicine

Background:

  • Limited data exists on the long-term survival benefits of cardiac rehabilitation programs.
  • Acute myocardial infarction (AMI) survivors require effective strategies to improve long-term prognosis.

Purpose of the Study:

  • To assess the impact of a structured cardiac rehabilitation program on long-term mortality in AMI patients.
  • To evaluate the effect of cardiac rehabilitation on morbidity in this patient cohort.

Main Methods:

  • 180 low-risk male patients under 65 years with AMI were randomized.
  • 90 patients participated in a comprehensive cardiac rehabilitation program; 90 served as controls.
  • Mean follow-up was 10 years.

Main Results:

  • All-cause mortality was significantly lower in the cardiac rehabilitation group (91.8% vs. 81.7% survival; P=.04).
  • Morbidity decreased significantly, with lower rates of non-fatal complications (35.2% vs. 63.2%; P=.03), unstable angina (15.7% vs. 33.9%; P=.02), heart failure (3.0% vs. 14.4%; P=.02), and need for coronary intervention (8.4% vs. 22.9%; P=.02).

Conclusions:

  • Comprehensive cardiac rehabilitation programs significantly reduce long-term mortality in low-risk AMI patients.
  • Cardiac rehabilitation effectively lowers morbidity, improving patient outcomes post-myocardial infarction.
Abstract

Related Concept Videos

Cardiomyopathy V: Interprofessional Care01:29

Cardiomyopathy V: Interprofessional Care

Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...
Coronary Artery Disease V: Interprofessional Care01:27

Coronary Artery Disease V: Interprofessional Care

Interprofessional care for coronary artery disease includes pharmacological therapy and revascularization procedures.Pharmacological therapy for Coronary Artery Disease (CAD) aims to manage symptoms, prevent complications, and improve patient outcomes through various classes of medications:Antiplatelet Agents:Aspirin and Clopidogrel: These medications inhibit platelet aggregation, preventing blood clots, which is crucial for avoiding heart attacks and strokes. Doctors often prescribe these...
Myocarditis IV: Nursing Management01:22

Myocarditis IV: Nursing Management

Myocarditis is an inflammatory condition of the myocardium requiring meticulous nursing management for optimal patient outcomes. Effective management begins with a thorough assessment of the patient's medical history, paying close attention to past infections, autoimmune disorders, travel history, and exposure to toxins or drugs. Recent viral infections and systemic diseases are particularly relevant due to their potential role in triggering myocarditis.Physical Examination and MonitoringThe...
Cardiomyopathy II: Dilated Cardiomyopathy01:30

Cardiomyopathy II: Dilated Cardiomyopathy

Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...
Acute Coronary Syndrome III: Diagnostic Studies01:30

Acute Coronary Syndrome III: Diagnostic Studies

Diagnosing acute coronary syndrome or ACS begins with a thorough patient history. Notable symptoms include central, crushing chest pain radiating to the left arm, neck, jaw, or back, along with shortness of breath, sweating (diaphoresis), nausea, vomiting, dizziness, and palpitations.It is crucial to note any history of cardiac illnesses and assess risk factors, including age, gender, smoking, hypertension, diabetes, hyperlipidemia, and a sedentary lifestyle.During physical examination, vital...
Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

Cardiomyopathy III: Hypertrophic Cardiomyopathy

Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...